Tag: Michael Vodicka

Secret CBD Company Grows Sales 1,300% in 12 Months

Posted on by The INO.com Team

Analysis originally distributed on June 15, 2017 By: Michael Vodicka of Cannabis Stock Trades

In the old days, pot was seen as a way to get stoned.

But now, researchers are discovering that pot can actually have many health benefits.

Most of those come from Cannabidiol - one of the most prevalent compounds found in hemp plants that is commonly refereed to as CBD on the Street.

Studies have shown that the non-psychoactive elements of CBD can deliver relief to a wide range of ailments, including aches, pains, anxiety, insomnia and arthritis - without the euphoric effects provided by THC.

These benefits are creating a huge growth market.

The Hemp Business Journal, a CBD media and data company, estimates the CBD market will grow to $2.1 billion in consumer sales by 2020. That would be a 700% increase from 2016.

This is an exciting segment of the cannabis industry that doesn't get a lot of attention. Continue reading "Secret CBD Company Grows Sales 1,300% in 12 Months" →

A 2nd Cannabis Stock With $1 Billion Drug Potential

Posted on by The INO.com Team

Analysis originally distributed on June 7, 2017 By: Michael Vodicka of Cannabis Stock Trades

Blockbuster drugs are the holy grail of the pharmaceutical and biotech industry.

When annual sales of a new drug break the $1 billion mark, investors are usually rewarded with big gains.

This is what began happening late 2012 with Gilead Science (NASDAQ:GILD).

In 2013 the FDA approved Gilead's hepatitis C drug Sovaldi.

Then, in 2014, Gilead scored an FDA approval for another Hep C drug, Harvoni.

Both drugs went on to quickly hit blockbuster status - sending shares of Gilead soaring - jumping more than 200% in the next two years. Take a look below.

GILD
Image courtesy of MarketClub.com

Today, the young cannabis industry is in hot pursuit of its first ever cannabis blockbuster - and I expect the winner of this race to deliver huge gains to shareholders. Continue reading "A 2nd Cannabis Stock With $1 Billion Drug Potential" →

Another 499% Gain In 18 Months On Tap?

Posted on by The INO.com Team

Analysis originally distributed on May 24, 2017 By: Michael Vodicka of Cannabis Stock Trades

Investing in cannabis IPOs for the last few years has been extremely profitable.

Take Aphria Inc. (APHFQ), one of Canada's largest medical cannabis companies, for example.

Shares began trading on the Toronto Stock Exchange in October of 2015.

Now, just 18 months later, Aphria is up 499%. Take a look below.Daily Chart Aphria Inc. (APHFQ)

Shares did get off to a slow start. And from there it wasn't a straight shot higher.

But as you can see, investors who bought early in the game are sitting on the biggest gains. And looking forward, early investors will still be collecting the biggest profits because they have the lowest cost basis.

If you're interested in profiting from future cannabis IPOs, you're in luck. Continue reading "Another 499% Gain In 18 Months On Tap?" →

Aurora Delivers 2,500% Revenue Growth in 12 Months

Posted on by The INO.com Team

Analysis originally distributed on May 19, 2017 By: Michael Vodicka of Cannabis Stock Trades

First-quarter earnings season is almost over.

And the cannabis sector has been knocking it out of the park.

A lot of the stocks that we have covered over the last few months have stepped up and delivered excellent results.

Let's take a closer look.

In terms of pure growth, the best report I've seen came from Aurora Cannabis (ACBFF), one of the largest medical cannabis companies in Canada

Revenue jumped 2,500% from the same period last year to $5.2 million and was up 33% from just last quarter. Continue reading "Aurora Delivers 2,500% Revenue Growth in 12 Months" →

First Ever Cannabis ETF: Friend or Foe?

Posted on by The INO.com Team

Analysis originally distributed on May 10, 2017 By: Michael Vodicka of Cannabis Stock Trades

If you like getting a good deal then once again the time has come to take a look at cannabis stocks.

The cannabis sector has fallen into a bear market. A bear market happens when a stock falls 20% or more from its 52-week high.

After posting massive gains in 2016 and early 2017 – the MJIC Index North American Cannabis Index is down 25% from its 52-week high. Take a look.

North American Marijuana Index

I don’t see any fundamental reason for the pullback. As always there has been plenty of good news coming out of the cannabis industry. Continue reading "First Ever Cannabis ETF: Friend or Foe?" →